Sohyun Bae
Overview
Explore the profile of Sohyun Bae including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Woo H, Kwon T, Heo S, Yoo J, Kim M, Oh J, et al.
BMC Infect Dis
. 2025 Feb;
25(1):274.
PMID: 40001073
Background And Aim: Severe fever with thrombocytopenia syndrome (SFTS) is a fatal tick-borne infectious disease lacking effective treatments or vaccines. Early identification of prognostic factors is essential for optimizing clinical...
2.
Chang H, Nam H, Kim H, Park K, Bae S, Kim Y, et al.
Infect Chemother
. 2025 Jan;
56(4):551-554.
PMID: 39762931
This retrospective study analyzed medical records of 1,392 people living with HIV (PLWH) diagnosed with latent tuberculosis infection (LTBI) at two provincial central hospitals from 2011 to 2022. LTBI was...
3.
Shin S, Bae S, Cho D, Lee A, Jeong H, Hwang S, et al.
BMC Infect Dis
. 2024 Dec;
24(1):1473.
PMID: 39732640
Background: Invasive fungal infections have been reported as complications with significant mortality and morbidity in patients hospitalized with COVID-19. This study aimed to evaluate the clinical characteristics and outcomes of...
4.
Yun D, Bae S, Gao Y, Lopez L, Han D, Nicora C, et al.
medRxiv
. 2024 Aug;
PMID: 39211860
Background: Mechanisms of progression of diabetic kidney disease (DKD) are not completely understood. This study uses untargeted and targeted mass spectrometry-based proteomics in two independent cohorts on two continents to...
5.
Lim J, Nam E, Seo Y, Jung H, Choi J, Cho J, et al.
Infect Chemother
. 2024 Jun;
56(3):329-338.
PMID: 38859715
Background: Solid-organ transplant recipients (SOTRs) receiving immunosuppressive therapy are expected to have worse clinical outcomes from coronavirus disease 2019 (COVID-19). However, published studies have shown mixed results, depending on adjustment...
6.
Kim S, Jang H, Chang H, Kim Y, Bae S
Infect Chemother
. 2024 Jun;
56(2):247-255.
PMID: 38859713
Background: A dual regimen with dolutegravir plus cobicistat-boosted darunavir (DTG+DRV/c) is a promising alternative for patients with human immunodeficiency virus (HIV) with resistance or intolerance to nucleoside reverse transcriptase inhibitors,...
7.
Bae S, Yun D, Lee S, Jhee J, Lee J, Chang T, et al.
BMC Nephrol
. 2024 May;
25(1):172.
PMID: 38769500
Background: Diabetic kidney disease (DKD) stands as the predominant cause of chronic kidney disease and end-stage kidney disease. Its diverse range of manifestations complicates the treatment approach for patients. Although...
8.
Kwon K, Kim Y, Kim S, Chang H, Hwang S, Bae S, et al.
J Korean Med Sci
. 2024 Apr;
39(14):e132.
PMID: 38622938
Background: Nationwide research on the association between carbapenem-resistant (CREs) and antibiotic use is limited. Methods: This nested case-control study analyzed Korean National Health Insurance claims data from April 2017 to...
9.
Hwang S, Lee N, Nam E, Kim Y, Kim S, Chang H, et al.
Infect Dis Ther
. 2024 Apr;
13(5):1037-1050.
PMID: 38607524
Introduction: Regdanvimab, a monoclonal antibody pharmaceutical, is the first Korean drug approved for treating coronavirus disease 2019 (COVID-19). We analyzed the therapeutic efficacy of regdanvimab in patients with the COVID-19...
10.
Lee S, Hwang S, Kwon K, Nam E, Chung U, Kim S, et al.
J Korean Med Sci
. 2024 Apr;
39(13):e120.
PMID: 38599597
Background: A healthcare system's collapse due to a pandemic, such as the coronavirus disease 2019 (COVID-19), can expose healthcare workers (HCWs) to various mental health problems. This study aimed to...